Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MNZO Manzo Pharmaceuticals Inc (CE)

0.00 (0.00%)
Feb 22 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0.00
Bid Price
Ask Price
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Manzo Pharmaceuticals Inc (CE) MNZO OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.000001 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.000001 0.000001
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.000001 - 0.000006
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.000001 USD

Manzo Pharmaceuticals Inc (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.10k 1.10B 374.24M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Manzo Pharmaceuticals (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No MNZO Message Board. Create One! See More Posts on MNZO Message Board See More Message Board Posts

Historical MNZO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.0000010.0000010.0000010.000001300,2000.000.00%
3 Months0.0000010.0000010.0000010.000001104,1670.000.00%
6 Months0.0000010.0000010.0000010.00000179,2830.000.00%
1 Year0.0000060.0000060.0000010.000001153,772-0.00001-83.33%
3 Years0.00070.00210.0000010.00059711,207,117-0.0007-99.86%
5 Years0.00020.00210.0000010.00049421,179,840-0.0002-99.50%

Manzo Pharmaceuticals (CE) Description

Manzo Pharmaceuticals, Inc. is without operations or a material amount of assets. The Issuer has conducted due dilligence, and has identified and is consumating a deal with, which is a Layer II, 'private over public' blockchain ICO and Crowdfunding platform. This ecosystem has been set up to do Intitial Coin Offerings that ascribe to the SEC's regulatory framework, with third party service providers. Ultimately, it is the objective to tokenize the issuer and offer an institutional grade security invested in precious metals, real estate, and issuers conducting ICOS. There is no assurance that the Issuer will be successful in this endeavor. A Shareholder's Meeting will be announced soon - to 'approve the acquisition', 'Regulation D #506 C Convertable Notes offers to Accredited Investors' and 'Plan of Reoganization'.

Your Recent History

Delayed Upgrade Clock